Latest Medical News from Russia

A year ago, "Olymp Clinic MARS" opened in Moscow with enhanced competencies in traumatology and orthopedics, sports medicine, and rehabilitation. The project became part of the "Olymp Health" Group of Companies, and its creator was renowned trauma surgeon-orthopedist Andrey Korolev, who was at the forefront of arthroscopic methods in Russia. In this interview with Marus Media, the professor discusses the organizational principles and initial results of the new project.

In 2026, cosmetology is changing its focus: instead of the idea of "minus ten years," customers are choosing naturalness, skin quality, and minimally rehabilitative procedures. Personalized protocols and a new generation of technologies are taking center stage. In this Marus Media article, practicing cosmetologists from leading Russian clinics comment on the key trends of the year and share which technologies are truly effective.

Aesthetic gynecology is increasingly emerging from the shadow of cosmetic procedures to become a tool for restoring function, comfort, and quality of life for women, from young mothers with postpartum incontinence to postmenopausal patients with mucosal atrophy.

Treating patients who have already undergone standard lines of cancer therapy is a critical task for oncologists. The method of choice in such cases becomes therapy with radioisotopes, or radionuclide therapy (RNT). About these capabilities in Russia, in this Marus Media review.

For the 9 months of 2025 compared to the same period in 2024, Russia's Ministry of Health recorded 25% growth in the financial volume of medical care provided to foreign citizens. The volume of treatment for patients with serious oncological, cardiological, and ophthalmological conditions increased particularly notably.

The Russian spa and resort industry is rapidly aging alongside its audience and is being forced to reinvent itself at the intersection of medicine, wellness, and tourism. Marus Media spoke with Ksenia Boretskaya, Director of the Department of Medicine and Wellness at Mriya Resort, about how guest expectations are changing, why biological age is becoming a performance metric on par with revenue, and what the government must do for sanatoriums to become part of the healthcare system.

The demand for sanatoriums in Russia is high, but the industry faces a problem: treatment programs are often replaced by "wellness" marketing products, which can harm patients with chronic conditions, even though sanatorium treatment is a vital stage in patient therapy and recovery. Aydarbek Isakhanov, an expert at the National Resort Association, explains what effective treatment programs should look like and how sanatoriums can generate revenue from them.

The FDA has approved a new indication for Keytruda (pembrolizumab), an immunotherapy drug by MSD (Merck & Co) and the world’s best-selling cancer medication. The drug can now be prescribed to ovarian cancer patients whose tumors have become resistant to standard chemotherapy. It is the first agent of its class to receive such approval.

In 2025, sales of semaglutide-based weight loss medications in Russian pharmacies amounted to 29.2 billion rubles ($378 million), which is almost three times higher than in the previous year (9.9 billion rubles, $128 million). This growth was driven by domestic manufacturers who actively started producing analogues of Novo Nordisk's original Ozempic.